UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine

Blood, 1992-09, Vol.80 (6), p.1443-1447

1992

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic growth-promoting effects of natural killer cells in mice in response to in vivo administration of human interleukin-2

JNCI : Journal of the National Cancer Institute, 1992-08, Vol.84 (15), p.1195-1200

1992

Link zum Volltext

Verfügbarkeit prüfen

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with Non-ST-Segment-Elevation acute coronary syndrome : Results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial

Circulation (New York, N.Y.), 2007-10, Vol.116 (15), p.1647-1652

2007

Link zum Volltext

Verfügbarkeit prüfen

HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan

Clinical cancer research, 2006-12, Vol.12 (24), p.7397-7405

2006

Link zum Volltext

Verfügbarkeit prüfen

Benzodiazepines as Potent and Selective Bradykinin B1 Antagonists

Journal of medicinal chemistry, 2003-05, Vol.46 (10), p.1803-1806

2003

Link zum Volltext

Verfügbarkeit prüfen

Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase

Biochemical pharmacology, 2006-05, Vol.71 (10), p.1422-1434

2006

Link zum Volltext

Verfügbarkeit prüfen

α-Hydroxy amides as a novel class of bradykinin B1 selective antagonists

Bioorganic & medicinal chemistry letters, 2008-01, Vol.18 (2), p.716-720

2008

Link zum Volltext

Verfügbarkeit prüfen

Development of Orally Bioavailable and CNS Penetrant Biphenylaminocyclopropane Carboxamide Bradykinin B1 Receptor Antagonists

Journal of medicinal chemistry, 2007-01, Vol.50 (2), p.272-282

2007

Link zum Volltext

Verfügbarkeit prüfen

Indazole derivatives as novel bradykinin B1 receptor antagonists

Bioorganic & medicinal chemistry letters, 2010-12, Vol.20 (23), p.7011-7014

2010

Link zum Volltext

Verfügbarkeit prüfen

2,3-Diaminopyridine Bradykinin B1 Receptor Antagonists

Journal of medicinal chemistry, 2004-12, Vol.47 (26), p.6439-6442

2004

Link zum Volltext

Verfügbarkeit prüfen

Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial

Diabetes care, 2000-12, Vol.23 (12), p.1823-1829

2000

Link zum Volltext

Verfügbarkeit prüfen

Cyclopropylamino Acid Amide as a Pharmacophoric Replacement for 2,3-Diaminopyridine. Application to the Design of Novel Bradykinin B1 Receptor Antagonists

Journal of medicinal chemistry, 2006-02, Vol.49 (4), p.1231-1234

2006

Link zum Volltext

Verfügbarkeit prüfen

A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity

Bioorganic & medicinal chemistry letters, 2008-01, Vol.18 (2), p.682-687

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia : A joint children's cancer group and pediatric oncology branch study

Blood, 1998-11, Vol.92 (10), p.3569-3577

1998

Link zum Volltext

Verfügbarkeit prüfen

Bradykinin B1 receptor antagonists : An α-hydroxy amide with an improved metabolism profile

Bioorganic & medicinal chemistry letters, 2008-09, Vol.18 (18), p.5107-5110

2008

Link zum Volltext

Verfügbarkeit prüfen

2-Aminobenzophenones as a Novel Class of Bradykinin B1 Receptor Antagonists

Journal of medicinal chemistry, 2008-07, Vol.51 (13), p.3946-3952

2008

Link zum Volltext

Verfügbarkeit prüfen

2,3-diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists

Bioorganic & medicinal chemistry letters, 2005-05, Vol.15 (9), p.2385-2388

2005

Link zum Volltext

Verfügbarkeit prüfen

Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting

Journal of clinical oncology, 1992-12, Vol.10 (12), p.1969-1975

1992

Link zum Volltext

Verfügbarkeit prüfen

The effects of TPA023, a GABAAα2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol

Journal of psychopharmacology (Oxford), 2012-02, Vol.26 (2), p.282-291

2012

Link zum Volltext

Verfügbarkeit prüfen

Bradykinin B1 antagonists : Biphenyl SAR studies in the cyclopropanecarboxamide series

Bioorganic & medicinal chemistry letters, 2007-07, Vol.17 (13), p.3608-3612

2007

Link zum Volltext

Verfügbarkeit prüfen

Bradykinin B1 antagonists : SAR studies in the 2,3-diaminopyridine series

Bioorganic & medicinal chemistry letters, 2005-09, Vol.15 (17), p.3925-3929

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of 131I-huA33 in Patients with Advanced Colorectal Carcinoma

Clinical cancer research, 2005-07, Vol.11 (13), p.4818-4826

2005

Link zum Volltext

Verfügbarkeit prüfen

5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists

Bioorganic & medicinal chemistry letters, 2006-05, Vol.16 (10), p.2791-2795

2006

Link zum Volltext

Verfügbarkeit prüfen

Preclinical and clinical pharmacology of TPA023 B, a GABAA receptor α2/α3 subtype-selective partial agonist

Journal of psychopharmacology (Oxford), 2011, Vol.25 (3), p.329-344

2011

Link zum Volltext

Verfügbarkeit prüfen

Potent bradykinin B1 receptor antagonists : 4-Substituted phenyl cyclohexanes

Bioorganic & medicinal chemistry letters, 2007-06, Vol.17 (11), p.3006-3009

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 68

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

ThemaPharmacology. Drug Treatments

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(64)
Tagungsberichte
(4)

Sprache

Englisch
(68)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(68)
Medical Sciences
(68)
Humans
(37)
Animals
(24)
Male
(24)
Rats
(19)
Neuropharmacology
(18)
Female
(17)
Bradykinin B1 Receptor Antagonists
(15)
Antineoplastic Agents
(14)
Structure-Activity Relationship
(14)
Adult
(13)
Middle Aged
(13)
Neurotransmitters. Neurotransmission. Receptors
(13)
Peptidergic System . Adenosinergic And Purinergic Systems
(13)
Aged
(11)
Chemotherapy
(8)
Dose-Response Relationship, Drug
(8)
Bradykinin
(7)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine

Hematopoietic growth-promoting effects of natural killer cells in mice in response to in vivo administration of human interleukin-2

HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan

Benzodiazepines as Potent and Selective Bradykinin B1 Antagonists

Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase

α-Hydroxy amides as a novel class of bradykinin B1 selective antagonists

Development of Orally Bioavailable and CNS Penetrant Biphenylaminocyclopropane Carboxamide Bradykinin B1 Receptor Antagonists

Indazole derivatives as novel bradykinin B1 receptor antagonists

2,3-Diaminopyridine Bradykinin B1 Receptor Antagonists

Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial

Cyclopropylamino Acid Amide as a Pharmacophoric Replacement for 2,3-Diaminopyridine. Application to the Design of Novel Bradykinin B1 Receptor Antagonists

A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity

Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia : A joint children's cancer group and pediatric oncology branch study

Bradykinin B1 receptor antagonists : An α-hydroxy amide with an improved metabolism profile

2-Aminobenzophenones as a Novel Class of Bradykinin B1 Receptor Antagonists

2,3-diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists

Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting

The effects of TPA023, a GABAAα2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol

Bradykinin B1 antagonists : Biphenyl SAR studies in the cyclopropanecarboxamide series

Bradykinin B1 antagonists : SAR studies in the 2,3-diaminopyridine series

Phase I Trial of 131I-huA33 in Patients with Advanced Colorectal Carcinoma

5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists

Preclinical and clinical pharmacology of TPA023 B, a GABAA receptor α2/α3 subtype-selective partial agonist

Potent bradykinin B1 receptor antagonists : 4-Substituted phenyl cyclohexanes

Aktive Filter

Suchergebnisse filtern